SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    George JN. How I treat patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Blood 2000; 96: 12231229.
  • 2
    Levy GG, Motto DG, Ginsburg D. ADAMTS13 turns 3. Blood 2005; 106: 1117.
  • 3
    George JN, Li X, McMinn JR, et al. Thrombotic thrombocytic purpura-hemolytic uremic syndrome following allogeneic HPC transplantation: A diagnostic dilemma. Transfusion 2004; 44: 294304.
  • 4
    Allford SL, Bird JM, Marks DI. Thrombotic thrombocytopenic purpura following stem cell transplantation. Leuk Lymphoma 2002; 43: 19211926.
  • 5
    Loirat C, Niaudet P. The risk of recurrence of hemolytic uremic syndrome after renal transplantation in children. Pediatr Nephrol 2003; 18: 10951101.
  • 6
    Chiurchiu C, Ruggenenti P, Remuzzi G. Thrombotic microangiopathy in renal transplantation. Ann Transplant 2002; 7: 2833.
  • 7
    Ramasubbu K, Mullick T, Koo A, et al. Thrombotic microangiopathy and cytomegalovirus in liver transplant recipients: A case-based review. Transpl Infect Dis 2003; 5: 98103.
  • 8
    Tamura S, Sugawara Y, Matsui Y, et al. Thrombotic microangiopathy in living-donor liver transplantation. Transplantation 2005; 80: 169175.
  • 9
    Chang JC, Shipstone A, Llenado-Lee MA. Postoperative thrombotic thrombocytopenia purpura following cardiovascular surgeries. Am J Hematol 1996; 53: 1117.
  • 10
    Pavlovsky M, Weinstein R. Thrombotic thrombocytopenic purpura following coronary artery bypass graft surgery: Prospective observations of an emerging syndrome. J Clin Apher 1997; 12: 159164.
  • 11
    Chang JC, El-Tarabily M, Gupta S. Acute thrombotic thrombocytopenic purpura following abdominal surgeries: A report of three cases. J Clin Apher 2000; 15: 176179.
  • 12
    Naqvi TA, Baumann MA, Chang JC. Post-operative thrombotic thrombocytopenic purpura: A review. Int J Clin Pract 2004; 58: 169172.
  • 13
    Chang JC, Ikhlaque N. Peripheral digit ischemic syndrome can be a manifestation of postoperative thrombotic thrombocytopenic purpura. Ther Apher Dial 2004; 8: 413418.
  • 14
    Robson MG, Abbs IC. Thrombotic thrombocytopenic purpura following hemicolectomy for colonic carcinoma. Nephrol Dial Transplant 1997; 12: 198199.
  • 15
    Kathula SK, Kamana M, Naqvi T, Gupta S, Chang JC. Acute thrombotic thrombocytopenic purpura following orthopedic surgery. J Clin Apher 2002; 17: 133134.
  • 16
    Cuttner J. Thrombotic thrombocytopenic purpura: A ten-year experience. Blood 1980; 56: 302306.
  • 17
    Kathula SK, Koduri J, Mall S, Chang JC. A case report of total abdominal hysterectomy resulting in acute thrombotic thrombocytopenic purpura with pancreatitis and hepatitis: Complete resolution with plasma exchange therapy. Ther Apher Dial 2003; 7: 373374.
  • 18
    Gerritsen HE, Turacek PL, Schwarz HP, et al. Assay of von Willibrand factor (vWF)—cleaving protease based on decreased collagen binding sffinity of degraded vWF: A tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP). Thromb Haemost 1999; 82: 13801381.
  • 19
    Caprioli J, Bettinaglio P, Zipfel PF, et al. The molecular basis of familial hemolytic uremic syndrome: Mutation analysis of factor H gene reveals a hot spot in short consensus repeat 20. J Am Soc Nephrol 2001; 12: 297307.
  • 20
    Caprioli J, Castelletti F, Bucchioni S, et al. Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: The C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease. Hum Mol Genet 2003; 12: 33853395.
  • 21
    Fujimura Y, Matsumoto M, Yagi H, Yoshioka A, Matsui T, Titani K. Von Willebrand factor-cleaving protease and Upshaw-Schulman syndrome. Int J Hematol 2002; 75: 2534.
  • 22
    Haspel RL, Jarolim P. The “cutting” edge: Von Willibrand factor-cleaving protease activity in thrombotic microangiopathies. Transfus Apher Sci 2005; 32: 177184.
  • 23
    Mori Y, Wada H, Gabazza EC, et al. Predicting response to plasma exchange in patients with thrombotic thrombocytopenic purpura with measurement of vWF-cleaving protease activity. Transfusion 2002; 42: 572580.
  • 24
    Vesley SK, George JN, Lammle B, et al. ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: Relation to presenting features and clinical outcomes in a prospective cohort of 142 patients. Blood 2003; 102: 6068.
  • 25
    Allan DS, Thompson CM, Barr RM, et al. Ciprofloxacin-associated hemolytic-uremic syndrome. Ann Pharmacother 2002; 36: 10001002.
  • 26
    Mouraux A, Gille M, Pieret F, et al. Fulminant thrombotic thrombocytopenic purpura in the course of ciprofloxacin therapy [Article in French]. Rev Neurol (Paris) 2002; 158: 11151117.